ABD-3001

• Description:

  ABD-3001 is an inhibitor of ALDH1. ABD-3001 can be studied in research on refractory/relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome[1].

• UNSPSC:

  12352211

• Target:

  Aldehyde Dehydrogenase (ALDH)

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Smiles:

  O=C(SC)C#CC(C)(C)N(C)C

• Molecular Formula:

  C9H15NOS

• Molecular Weight:

  185.29

• References & Citations:

  [1]Lina Benajiba, et al., Odyssey: A First-in-Human Study of the Aldehyde Dehydrogenase (ALDH) Inhibitor Abd-3001 in Patients with Refractory/Relapsed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) . Blood, 2024 144 (1) : 6001.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [350229-29-7]